First Page | Meta Content | |
---|---|---|
Document Date: 2011-08-23 05:57:47Open Document File Size: 175,76 KBShare Result on FacebookCompanyEuropean Biopharmaceutical Enterprises / OMPs / Health Care Systems / /ContinentEurope / /CountryFrance / United States / /CurrencyEUR / / /IndustryTermbiotechnology associations / biopharmaceutical / pharmaceutical industry federation / biotechnology / pharmaceutical industry / biotechnology products / diagnostic tools / health technology assessment / healthcare policies / manufacturing / health systems / biotechnology arm / care systems / biopharmaceutical industry / medicinal products / orphan medicinal products / /MedicalConditioneach rare disease / specific diseases / Rare Diseases / disease / rare cancers / chronic / musculoskeletal disorders / diseases / /Organizationoffice of Health Economics / Joint EBE/EuropaBio Task Force on Rare Diseases / European Association for Bioindustries / Joint Task Force / EBE/EuropaBio Task Force on Rare Diseases & Orphan Medicinal Products / European Union / /PersonEmmanuel Chantelot / / /Positiondriver / Executive Director / Director / EuropaBio l.lacaine@europabio.org / /ProgrammingLanguageEC / /PublishedMediumHealth Economics / /Technologybiotechnology / /SocialTag |